KALEB KENNEASTER: Open Payments
NPI 1295363083 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 43 payments from 19 companies in 2025. Trend: 2023 $413 · 2024 $1,339 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $142 |
| Abbott Laboratories | 5 | $106 |
| Lundbeck LLC | 3 | $89 |
| Lilly USA, LLC | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| Novo Nordisk Inc | 3 | $62 |
| PFIZER INC. | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| Boston Scientific Corporation | 1 | $36 |
| Amgen Inc. | 2 | $35 |
Products named: FREESTYLE LIBRE 3, REXULTI, MOUNJARO, BREZTRI, CAPLYTA, ELIQUIS, TZIELD, General - Pain Management.
Industry payments across OH — which companies pay providers there.
